Smithfield Foods Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 28, 2025 · FY), Smithfield Foods Inc reported revenue of $15.5B (+9.8% year on year) and net income of $998.0M (+25.1% year on year).
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Jan 3, 2016 · FY |
|---|---|---|---|
| Sales | $15.5B | $14.1B | $14.4B |
| Cost of sales | $13.4B | $12.2B | $12.7B |
| Gross profit | $2.1B | $1.9B | $1.8B |
| Selling, general and administrative expenses | $849.0M | $840.0M | $973.3M |
| Operating gains | ($52.0M) | ($60.0M) | — |
| Operating profit (loss) | $1.3B | $1.1B | $793.8M |
| Interest expense, net | $41.0M | $66.0M | — |
| Non-operating gains | ($18.0M) | ($9.0M) | — |
| Income (loss) from continuing operations before income taxes | $1.3B | $1.1B | — |
| Income tax expense (benefit) | $283.0M | $271.0M | $195.6M |
| (Income) loss from equity method investments | ($12.0M) | ($8.0M) | ($11.7M) |
| Net income (loss) from continuing operations | $998.0M | $798.0M | — |
| Net income from continuing operations attributable to noncontrolling interests | $11.0M | $14.0M | — |
| Net income (loss) from continuing operations attributable to Smithfield | $987.0M | $783.0M | — |
| Income from discontinued operations before income taxes | $0 | $184.0M | — |
| Income tax expense from discontinued operations | $0 | $13.0M | — |
| Net income from discontinued operations | $0 | $172.0M | — |
| Net income from discontinued operations attributable to noncontrolling interests | $0 | $2.0M | — |
| Net income from discontinued operations attributable to Smithfield | $0 | $170.0M | — |
| Net income | $998.0M | $970.0M | — |
| Net income attributable to noncontrolling interests | $11.0M | $17.0M | — |
| Continuing operations (in dollars per share) | $2.52 | $2.06 | — |
| Total (in dollars per share) | $2.52 | $2.51 | — |
| Continuing operations (in dollars per share) | $2.51 | $2.06 | — |
| Discontinued operations (in dollars per share) | $0.00 | $0.45 | — |
| Total (in dollars per share) | $2.51 | $2.51 | — |
| Basic (in shares) | 392.0M | 380.1M | — |
| Diluted (in shares) | 392.7M | 380.1M | — |
| Line item | Jun 28, 2026 · Q2 | Mar 29, 2026 · Q1 | Sep 28, 2025 · Q3 | Jun 29, 2025 · Q2 |
|---|---|---|---|---|
| Sales | $3.7B | $3.8B | $3.7B | $3.8B |
| Cost of sales | $3.2B | $3.3B | $3.3B | $3.3B |
| Gross profit | $478.0M | $511.0M | $479.0M | $499.0M |
| Selling, general and administrative expenses | $191.0M | $180.0M | $178.0M | $268.0M |
| Operating gains | ($3.0M) | ($1.0M) | ($9.0M) | ($30.0M) |
| Operating profit | $290.0M | $333.0M | $310.0M | $260.0M |
| Interest expense, net | $8.0M | $8.0M | $11.0M | $11.0M |
| Non-operating (gains) losses | ($17.0M) | $1.0M | ($19.0M) | ($4.0M) |
| Income before income taxes | $299.0M | $323.0M | $318.0M | $254.0M |
| Income tax expense | $64.0M | $72.0M | $71.0M | $62.0M |
| (Income) loss from equity method investments | ($4.0M) | $2.0M | ($4.0M) | $3.0M |
| Net income | $239.0M | $249.0M | $252.0M | $188.0M |
| Net income attributable to noncontrolling interests | $1.0M | $4.0M | $4.0M | $0 |
| Net income attributable to Smithfield | $238.0M | $246.0M | $248.0M | $188.0M |
| Basic (in dollars per share) | $0.61 | $0.63 | $0.63 | $0.48 |
| Diluted (in dollars per share) | $0.60 | $0.62 | $0.63 | $0.48 |
| Basic (in shares) | 393.5M | 393.3M | 393.1M | 393.1M |
| Diluted (in shares) | 395.8M | 394.7M | 394.6M | 393.8M |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Jan 3, 2016 · FY |
|---|---|---|---|
| Cash and cash equivalents | $1.5B | $943.0M | $704.9M |
| Accounts receivable, net | $1.0B | $558.0M | $760.0M |
| Inventories, net | $2.3B | $2.4B | $2.1B |
| Prepaid expenses and other current assets | $276.0M | $290.0M | $176.4M |
| Total current assets | $5.2B | $4.2B | $3.7B |
| Property, plant and equipment, net | $3.2B | $3.2B | $2.9B |
| Goodwill | $1.6B | $1.6B | $1.6B |
| Intangible assets, net | $1.3B | $1.3B | $1.4B |
| Operating lease assets | $387.0M | $335.0M | — |
| Equity method investments | $209.0M | $202.0M | $142.5M |
| Other assets | $306.0M | $260.0M | $158.0M |
| Total assets | $12.2B | $11.1B | $9.9B |
| Accounts payable | $856.0M | $777.0M | $686.1M |
| Current portion of long-term debt and finance lease obligations | $3.0M | $3.0M | $30.3M |
| Current portion of operating lease obligations | $71.0M | $56.0M | — |
| Accrued expenses and other current liabilities | $811.0M | $871.0M | $828.3M |
| Total current liabilities | $1.7B | $1.7B | $1.5B |
| Long-term debt and finance lease obligations | $2.0B | $2.0B | $2.3B |
| Long-term operating lease obligations | $322.0M | $286.0M | — |
| Deferred income taxes, net | $658.0M | $518.0M | $668.2M |
| Net long-term pension obligation | $207.0M | $279.0M | — |
| Other liabilities | $185.0M | $208.0M | $116.8M |
| Redeemable noncontrolling interests | $264.0M | $225.0M | $53.9M |
| Preferred stock, no par value; 100,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | — |
| Common stock, no par value; 5,000,000,000 shares authorized; 393,112,711 shares issued and outstanding as of December 28, 2025 and 380,069,232 shares issued and outstanding as of December 29, 2024 | 0 | 0 | — |
| Additional paid-in capital | $3.3B | $3.1B | $4.2B |
| Retained earnings | $3.8B | $3.2B | $1.0B |
| Accumulated other comprehensive loss | ($314.0M) | ($452.0M) | ($377.7M) |
| Total shareholders’ equity | $6.8B | $5.8B | $4.8B |
| Total liabilities and equity | $12.2B | $11.1B | $9.9B |
| Line item | Jun 28, 2026 | Mar 29, 2026 | Sep 28, 2025 | Jun 29, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.4B | $1.4B | $773.0M | $928.0M |
| Accounts receivable, net | $1.0B | $1.1B | $1.0B | $773.0M |
| Inventories, net | $2.4B | $2.3B | $2.5B | $2.3B |
| Prepaid expenses and other current assets | $267.0M | $232.0M | $313.0M | $302.0M |
| Total current assets | $5.0B | $5.0B | $4.6B | $4.3B |
| Property, plant and equipment, net | $3.2B | $3.2B | $3.2B | $3.2B |
| Goodwill | $1.6B | $1.6B | $1.6B | $1.6B |
| Intangible assets, net | $1.3B | $1.3B | $1.3B | $1.3B |
| Operating lease assets | $385.0M | $380.0M | $381.0M | $380.0M |
| Equity method investments | $213.0M | $209.0M | $202.0M | $203.0M |
| Other assets | $315.0M | $297.0M | $273.0M | $254.0M |
| Total assets | $12.0B | $12.0B | $11.5B | $11.2B |
| Accounts payable | $461.0M | $489.0M | $597.0M | $444.0M |
| Current portion of long-term debt and finance lease obligations | $602.0M | $602.0M | $3.0M | $3.0M |
| Current portion of operating lease obligations | $73.0M | $73.0M | $69.0M | $68.0M |
| Accrued expenses and other current liabilities | $818.0M | $922.0M | $811.0M | $824.0M |
| Total current liabilities | $2.0B | $2.1B | $1.5B | $1.3B |
| Long-term debt and finance lease obligations | $1.4B | $1.4B | $2.0B | $2.0B |
| Long-term operating lease obligations | $319.0M | $313.0M | $318.0M | $318.0M |
| Deferred income taxes, net | $631.0M | $638.0M | $581.0M | $503.0M |
| Net long-term pension obligation | $206.0M | $209.0M | $215.0M | $271.0M |
| Other liabilities | $187.0M | $180.0M | $204.0M | $209.0M |
| Redeemable noncontrolling interests | $311.0M | $311.0M | $257.0M | $245.0M |
| Preferred stock, no par value; 100,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | 0 | 0 |
| Common stock, no par value; 5,000,000,000 shares authorized; 393,760,231 shares issued and outstanding as of June 28, 2026 and 393,112,711 shares issued and outstanding as of December 28, 2025 | 0 | 0 | 0 | 0 |
| Additional paid-in capital | $3.3B | $3.3B | $3.3B | $3.3B |
| Retained earnings | $4.0B | $3.9B | $3.5B | $3.4B |
| Accumulated other comprehensive loss | ($304.0M) | ($325.0M) | ($414.0M) | ($432.0M) |
| Total shareholders’ equity | $7.0B | $6.9B | $6.5B | $6.3B |
| Total liabilities and equity | $12.0B | $12.0B | $11.5B | $11.2B |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Jan 3, 2016 · FY |
|---|---|---|---|
| Net income | $998.0M | $970.0M | — |
| Less: Net income from discontinued operations | $0 | ($172.0M) | — |
| Net income (loss) from continuing operations | $998.0M | $798.0M | — |
| Depreciation and amortization | $332.0M | $339.0M | $234.1M |
| Deferred income tax expense | $94.0M | — | $63.9M |
| Stock compensation expense | $9.0M | — | — |
| (Gain) loss on sale of property, plant and equipment and other assets | $12.0M | ($35.0M) | — |
| (Income) loss from equity method investments | ($12.0M) | ($8.0M) | ($11.7M) |
| Gain on assets held in rabbi trusts | ($34.0M) | — | — |
| Change in accounts receivable | ($470.0M) | ($6.0M) | $83.5M |
| Change in inventories | $118.0M | $138.0M | $141.5M |
| Change in prepaid expenses and other current assets | ($6.0M) | ($88.0M) | $66.8M |
| Change in accounts payable | $65.0M | ($19.0M) | $19.8M |
| Change in accrued expenses and other current liabilities | ($63.0M) | ($261.0M) | — |
| Other | $17.0M | ($49.0M) | ($151.1M) |
| Net cash flows from operating activities of continuing operations | $1.1B | $916.0M | — |
| Capital expenditures | ($341.0M) | ($350.0M) | ($375.2M) |
| Net expenditures from breeding stock transactions | ($14.0M) | ($43.0M) | — |
| Investments in partnerships and other assets | ($12.0M) | ($13.0M) | — |
| Business dispositions | $0 | $15.0M | — |
| Proceeds from sale of property, plant and equipment and other assets | $14.0M | $99.0M | $6.4M |
| Cash receipts on notes receivable | $25.0M | — | — |
| Other | $18.0M | $9.0M | ($6.0M) |
| Net cash flows used in investing activities of continuing operations | ($309.0M) | ($298.0M) | ($75.0M) |
| Payment of dividends | ($396.0M) | ($288.0M) | ($30.0M) |
| Principal payments on long-term debt and finance lease obligations | ($3.0M) | ($24.0M) | — |
| Payment of deferred purchase consideration for acquisition | ($2.0M) | ($2.0M) | — |
| Repayments to Securitization Facility | $0 | ($14.0M) | — |
| Proceeds from Securitization Facility | $0 | $14.0M | $290.0M |
| Net repayments to revolving credit facilities | $0 | ($8.0M) | — |
| Purchase of redeemable noncontrolling interest | $0 | $0 | — |
| Net proceeds from issuance of common stock | $236.0M | — | — |
| Other | $1.0M | $1.0M | $0 |
| Net cash flows used in financing activities of continuing operations | ($164.0M) | ($321.0M) | ($446.5M) |
| Effect of foreign exchange rate changes on cash from continuing operations | $11.0M | ($7.0M) | — |
| Net cash flows from operating activities of discontinued operations | $0 | $221.0M | — |
| Net cash flows used in investing activities of discontinued operations | $0 | ($171.0M) | — |
| Net cash flows used in financing activities of discontinued operations | $0 | ($143.0M) | — |
| Effect of foreign exchange rate changes on cash from discontinued operations | $0 | ($5.0M) | — |
| Net change in cash and cash equivalents of discontinued operations | $0 | ($98.0M) | — |
| Net change in cash, cash equivalents and restricted cash | $597.0M | $192.0M | — |
| Cash, cash equivalents and restricted cash at beginning of period (including discontinued operations) | $1.5B | $751.0M | — |
| Less: Cash, cash equivalents and restricted cash attributable to discontinued operations at end of period | $0 | $0 | — |
| Cash, cash equivalents and restricted cash at end of period | $1.5B | $943.0M | — |
| Line item | Jun 28, 2026 · YTD | Mar 29, 2026 · Q1 | Sep 28, 2025 · YTD | Jun 29, 2025 · YTD |
|---|---|---|---|---|
| Net income | $489.0M | $249.0M | $667.0M | $415.0M |
| Depreciation and amortization | $169.0M | $83.0M | $248.0M | $165.0M |
| Changes in operating and other assets and liabilities, net | ($436.0M) | ($390.0M) | ($794.0M) | ($446.0M) |
| Other | ($18.0M) | ($8.0M) | $0 | ($27.0M) |
| Net cash flows from operating activities | $204.0M | ($65.0M) | — | — |
| Capital expenditures | ($165.0M) | ($88.0M) | ($246.0M) | ($158.0M) |
| Net expenditures from breeding stock transactions | ($15.0M) | ($6.0M) | ($9.0M) | ($13.0M) |
| Cash receipts on notes receivable | $29.0M | $14.0M | $14.0M | — |
| Net cash flows used in investing activities | ($150.0M) | ($80.0M) | — | — |
| Payment of dividends | ($246.0M) | — | ($297.0M) | ($197.0M) |
| Net proceeds from issuance of common stock | $0 | $0 | $236.0M | $236.0M |
| Other | $0 | ($5.0M) | ($2.0M) | ($1.0M) |
| Net cash flows from (used in) financing activities | ($246.0M) | ($5.0M) | — | — |
| Effect of foreign exchange rate changes on cash | $3.0M | ($4.0M) | — | — |
| Net change in cash, cash equivalents and restricted cash | ($189.0M) | ($154.0M) | ($170.0M) | ($15.0M) |
| Cash, cash equivalents and restricted cash at beginning of period | $1.5B | $1.5B | — | $943.0M |
| Cash, cash equivalents and restricted cash at end of period | $1.4B | $1.4B | $773.0M | $928.0M |
Smithfield Foods Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.